Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

MBOT Microbot Medical Inc

Price (delayed)

$2.76

Market cap

$100.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.65

Enterprise value

$97.28M

Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary ...

Highlights
MBOT's quick ratio has soared by 197% YoY
Microbot Medical's EPS has increased by 27% YoY and by 11% QoQ
Microbot Medical's debt has decreased by 34% YoY but it has increased by 24% from the previous quarter
MBOT's net income is down by 14% year-on-year and by 2% since the previous quarter

Key stats

What are the main financial stats of MBOT
Market
Shares outstanding
36.38M
Market cap
$100.4M
Enterprise value
$97.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.31
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$12.26M
Net income
-$11.67M
EBIT
-$11.67M
EBITDA
-$11.6M
Free cash flow
-$9.31M
Per share
EPS
-$0.65
EPS diluted
-$0.65
Free cash flow per share
-$0.3
Book value per share
$0.83
Revenue per share
$0
TBVPS
$0.99
Balance sheet
Total assets
$30.89M
Total liabilities
$1.94M
Debt
$138,000
Equity
$28.95M
Working capital
$28.76M
Liquidity
Debt to equity
0
Current ratio
16.19
Quick ratio
16.08
Net debt/EBITDA
0.27
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-94.2%
Return on equity
-110.3%
Return on invested capital
-139.3%
Return on capital employed
-40.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
1.1%
1 week
-2.47%
1 month
15.48%
1 year
142.11%
YTD
146.43%
QTD
82.78%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.26M
Net income
-$11.67M
Gross margin
N/A
Net margin
N/A
MBOT's operating income is down by 32% year-on-year and by 5% since the previous quarter
MBOT's net income is down by 14% year-on-year and by 2% since the previous quarter

Price vs fundamentals

How does MBOT's price correlate with its fundamentals

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
3.31
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 27% YoY and by 11% QoQ
The stock's price to book (P/B) is 3.4% more than its 5-year quarterly average of 3.2 but 2.6% less than its last 4 quarters average of 3.4

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital has surged by 61% QoQ and by 40% YoY
The ROE has soared by 53% from the previous quarter and by 26% YoY
MBOT's return on assets is up by 46% since the previous quarter and by 19% year-on-year

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
MBOT's quick ratio has soared by 197% YoY
The current ratio has soared by 173% YoY
Microbot Medical's debt is 100% less than its equity
Microbot Medical's debt to equity has shrunk by 100% QoQ and by 100% YoY
Microbot Medical's debt has decreased by 34% YoY but it has increased by 24% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.